Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

If you use oxygen or inhalers, keep them within reach during practice. Generally, there aren’t specific exercises to avoid with COPD. That said, before beginning any exercise program ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...